GlassScriptPhysician profile
Alexa L Martin
NPI 1598145732
$4,661.98
in general payments reported to CMS, 2019-2025
35 companies · $1,461 in 2025
The $1,461 reported for 2025 was more than what 92% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $82.52 · 2022: $418 · 2023: $1,306 · 2024: $1,395 · 2025: $1,461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,982 · Education: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,981.89 |
| Education | $179.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $855.36 | 2021-2025 | Fasenra, Breztri, Airsupra |
| Jazz Pharmaceuticals INC. | $416.92 | 2022-2025 | Xywav |
| Grifols USA, LLC | $288.79 | 2022-2025 | Prolastin-C Liquid, Xembify, Gamunex-C |
| United Therapeutics Corporation | $273.81 | 2023-2025 | Tyvaso, Tyvaso, Orenitram |
| Regeneron Healthcare Solutions, INC. | $210.20 | 2024-2025 | Dupixent |
| Csl Behring | $198.91 | 2022-2025 | Kcentra |
| Mylan Specialty L.P. | $193.85 | 2023-2024 | Yupelri |
| Abbvie INC. | $182.07 | 2022-2025 | |
| Glaxosmithkline, LLC. | $179.54 | 2022-2025 | Nucala, Arexvy |
| Genentech USA, INC. | $176.11 | 2022-2025 | Xolair |
| Boehringer Ingelheim Pharmaceuticals, INC. | $164.56 | 2022-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Mallinckrodt Hospital Products INC. | $136.38 | 2022-2025 | Acthar |
| Harmony Biosciences LLC | $135.09 | 2023-2024 | Wakix |
| Amgen INC. | $121.58 | 2022-2025 | Tezspire |
| Merck Sharp & Dohme LLC | $113.80 | 2023-2025 | Zerbaxa, Winrevair, Recarbrio |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $101.13 | 2022-2025 | |
| Genzyme Corporation | $97.74 | 2024-2025 | |
| Ani Pharmaceuticals, INC. | $88.29 | 2022-2023 | Purified Cortrophin Gel |
| Actelion Pharmaceuticals US, INC. | $83.79 | 2023-2025 | Opsumit, Uptravi |
| Axsome Therapeutics, INC. | $83.20 | 2024-2025 | Sunosi |
| Viatris Specialty LLC | $66.65 | 2025 | Yupelri |
| Baxter Healthcare | $65.75 | 2023-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Idorsia Pharmaceuticals US INC | $64.41 | 2022-2024 | Quviviq |
| Novartis Pharmaceuticals Corporation | $47.44 | 2023-2024 | |
| Electromed, INC. | $45.58 | 2024-2025 | Smartvest |
| Takeda Pharmaceuticals U.S.A., INC. | $43.89 | 2025 | Glassia |
| Lilly USA, LLC | $36.68 | 2025 | Zepbound |
| Philips North America LLC | $33.20 | 2024-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Verona Pharma, INC. | $31.85 | 2025 | Ohtuvayre |
| Avadel Cns Pharmaceuticals, LLC | $27.09 | 2024 | Lumryz |
| Teva Pharmaceuticals USA, INC. | $25.65 | 2022-2023 | |
| Insmed, INC. | $22.60 | 2025 | Arikayce |
| Zoll Respicardia, INC. | $20.04 | 2023 | Remede System |
| Siemens Medical Solutions USA, INC. | $16.66 | 2024 | Cios Spin |
| Pulmonx Corporation | $13.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexa Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.